(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device was returned for analysis.The reported packaging issues (unsealed tyvek pouch) was confirmed.The xience sierra everolimus eluting coronary stent system, instructions for use (ifu) states: to confirm sterility has been maintained, ensure that the inner package sterile barrier has not been opened or damaged prior to use.The ifu deviation does not appear to have directly caused or contributed to the reported damage.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported unsealed device packaging appears to be related to a potential product quality issue.The issue is being addressed per internal operating procedures.Abbott vascular will continue to trend the performance of these devices.
|
It was reported that the procedure was performed to treat a 90% stenosed, mildly tortuous, mildly calcified, and concentric lesion in the mid left anterior descending artery.The tyvek inner pouch of a 3.25x15mm xience sierra stent delivery system was not sealed.The outer foil pouch was sealed.The stent was successfully deployed.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|